مقايسه سطح سرمي آنتي بادي پنوموني كلاميديا دربيماران با سكته قلبي حاد و گروه كنترل

Title

A comparison of clamydia pneumonia antibody serum levels in patients with acute myocardial infarction and control group

English Abstract

Introduction: Atherosclerosis is the major underlining cause of coronary artery disease including acute myocardial infarction (AMI), and AMI is one of the most common causes of human mortality in the world today. Many factors may have roles in generation or accentuation of atherosclerosis and recently it has been found that among the numerous agents resulting to atherosclerosis, infective agents can have a special role. In this survey, we studied the anti-clamydia pneumonia antibody serum levels in 60 patients with AMI and compared it with control group. Materials and methods: This study was done as case-control manner in a 6 month period in Ardabil Bouali Hospital and the serum level of anti-clamydia pneumonia antibody(IgG) was detected by immunoassay method in 60 patients with AMI admitted in CCU section. The same test was done in control group that were 60 cases and approximately similar in gender and age with AMI group. The cases of control group were selected from other sections of hospital with regard to not having known heart disease. Results: In total, 60 patient with AMI and 60 cases as control group were studied in this survey that 80% of each group were male and 20% were female and the age range in each group was 35-80 years. 63% of AMI group had anterior, the rest had inferior AMI. IgG serum titer in all of the patients of case and control groups was positive and above 5 unit/ml. Conclusion: As mentioned above, there was no significant statistical difference between anti-clamydia pneumonia IgG serum titer in case and control groups.

Document Downloads